Raytheon Technologies Corporation (NYSE:RTX) changes shares on Thursday trading session, with a change of -0.27% or -$0.16 shares. The trading starts at $59.50 and closed at $60.03 throughout the day. The trading session low price was $59.30 and day high was $60.41 on Thursday, August 06. After the session, the Industrials sector daily volume shifted to 5.78 million while its average volume is 11.12M. In other hand, the RTX market cap reached to $92.72B. While, its current target price is $76.25.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 4.19% and down -1.87% for month. Its quarterly performance was 5.02% above, while its half year performance is down -35.02%. RTX yearly performance stood at negative -21.32% and fall -32.22% for year-to-date. Current recommendation for Raytheon Technologies Corporation is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. RTX EPS (TTM) for 12-month is 0.41. EPS for this year is -13.70%, while for the next year its value is 3.74. Its EPS Q/Q reached -286.90%. It has an EPS of -0.70% down for past five years and for the next five years will be down -13.25%.
Let’s take a look on the analyst recommendations on RTX for the current month and previous month. For the current month, 11 of 19 analysts recommend stock as Buy while 0 as Sell, 3 as overweight, 0 as underweight and 5 as Hold. As compared with the previous month ratings, 21 analysts participate in stock recommendation. Out of 21, 0 rated it sell, 12 rated it as Buy and 6 as Hold Ratings. On the other hand, target price ranges from $62.00 – $101.00. Average target price for RTX was reached at $77.56.
The insider ownership moved to 0.10% and institutional holding shifted to 48.80%.
The company posted an EPS (TTM) of 0.41. According to the most recent quarter report on Name, RXT analysts estimated an average EPS of RTX, while Heron Therapeutics, Inc. EPS posted a year ago period. Analyst Estimated EPS for RTX published in the report was $Seagate Technology PLC – $Vertex Pharmaceuticals Incorpor during the same period.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for RTX fall -18.51% for period of 200 days. SMA for 50 days was -5.29% which is showing red signal, while SMA-20 was -0.96%.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in RTX stock. On Jul 31, Winnefeld James A Jr, Director, bought 407 trading shares at the cost of $56.55, which valued at 23016.0.